Endovascular Case Study
Find out how we support the development of an endovascular patch.
£4.5M Investment Led by Confluent Medical
Proceeds to be used to expand electrospinning capabilities & capacity, driving company growth Harwell, UK, May 4 2021 – The Electrospinning Company (Electrospinning), a leader in the development and manufacture of nanofibrous biomaterials for use in tissue regenerative devices, has completed a £4.5m ($6.3m) fundraising round, led by US materials science company Confluent Medical Technologies Inc. (Confluent) as a strategic investor…. Read more »
Corneal Case Study
Read how close partnership with our client helped overcome technological & pandemic challenges.
We are happy to announce we have been recertified ISO13485:2016 standard for a further three years. Read more about our Quality Assurance by visiting our Quality Assurance page.
Advisory Board: Appointed High Sheriff
Professor Harminder S. Dua has been appointed High Sheriff of Nottinghamshire on Saturday, 13 March 2021, due to he’s break-through contribution in Ophthalmology. We are honored to have a leading expert in the field of Ophthalmology as part of our scientific advisory board. Professor Harminder S. Dua joined our scientific advisory board in June 2020…. Read more »
Electrospun Materials in Neuroscience
Our Mimetix® Aligned fibres (TECL 006) were once again used as a pivotal tool to study oligodendrocytes in vitro. Oligodendrocytes produce myelin which plays a key role in the signal transduction by neurons. These oligodendrocytes exist in different populations and the authors investigated whether the location of these various populations correlates with their function. Published… Read more »
Setting Standards for Synthetic Biomaterials
The ASTM International defines and sets global standards across industries; these standards are used to improve product quality, enhance health and safety, strengthen market access, and trade, and build consumer confidence. Standardisation is an important factor in the medical field and being a part of this committee gives us the platform to influence and help… Read more »
Cell Therapy Blog: In conversation with Professor John Hunt
We are joined by Professor John Hunt, Research Theme lead for Medical Technologies and Advanced Materials at Nottingham Trent University and the academic lead for the Medical Technologies Innovation Facility (MTIF). John has over 3 decades of experience developing breakthrough therapies, devices and technology to repair, replace, augment and in the future regenerate diseased, infected… Read more »
Bringing Biomaterials to the Fore in Cell Therapy
Reading Time ~ 8 minutes Despite the success of cell therapies in some areas, such as CAR-T cells for lymphomas, translation to the clinic has generally been much less rapid and impactful than originally anticipated. One of the reasons for this may be that most of the attention has been focused on the cells themselves… Read more »
Microscaffold Patent Granted
On 23 June 2020, the UK patent office issued the Microscaffold patent (GB2544748A). Our custom Microscaffolds can be made from a large variety of materials and sizes, tailored towards their desired application. Their open, porous, three-dimensional structure allows for facile cell attachment and integration over a large range of cell types. These scaffolds can form… Read more »
In a new publication titled “A synergistic relationship between PCL and natural polymers enhances the physical properties and biological activity of scaffolds”, researchers at RAFT have shown the versatility of our Mimetix Air® scaffolds to be combined with natural polymer such as collagen, elastin and fibrin, with industrially applicable production methods. Their work shows how… Read more »
Angiogenesis on Mimetix Air scaffolds
Standard and modified Mimetix Air® scaffolds were used in a recent study to establish an improved method to measure new blood vessel formation (angiogenesis). Angiogenesis is an important natural process for healing and regeneration in the body. In “Pre-screening the intrinsic angiogenic capacity of biomaterials in an optimised ex ovo chorioallantoic membrane model” the group… Read more »